Cardiology: Real-World Tactics to Address Health InequitiesPremiere Date: Thursday, December 29, 2022
This activity offers CE credit for:%>
- ABIM (MOC)
- Medicine (accme)
- Nursing (ANCC)
- Pharmacy (acpe)
- PA (aapa)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, January 29, 2026
|Monica E. Peek, MD, MPH, MSc (Moderator)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
|Rachel M. Bond, MD, FACC
System Director, Women's Heart Health Dignity Health
Assistant Professor, Department of Internal Medicine
Creighton University School of Medicine
Co-Chair, Women's and Children's Committee Association of Black Cardiologists, Inc.
|Utibe R. Essien, MD, MPH
Assistant Professor of Medicine
Assistant Vice Chair, Equity Diversity and Inclusion
Department of Medicine
David Geffen School of Medicine at University of California, Los Angeles
Los Angeles, CA
Atrial fibrillation (AF) is the most common arrhythmia seen around the world. More than 12 million people in the United States will have AF by 2030, quintupling their risk for severe ischemic strokes. While the introduction of direct oral anticoagulants (DOACs) has enhanced stroke prophylaxis in AF, these medications are not equitably offered to all individuals, for a variety of reasons – both explicit and implicit.
In this CME Outfitters BriefCase activity, an expert faculty follows the journey of a 48-year-old Black female with AF to illuminate disparities in the quality of care she is offered. Frank questions and candid discussions about the impact of implicit bias, social determinants of health, shared decision making, and health literacy provide actionable and individualized strategies to improve outcomes for all patients with AF.
At the end of this CE activity, participants should be able to:
- Identify the impact of health inequities in cardiology patients with atrial fibrillation.
- Individualize a holistic treatment plan for cardiology care to improve patient outcomes.
Supported by an educational grant from Johnson & Johnson.
Physicians, PAs, NPs, nurses, pharmacists, specializing in cardiology, surgery, primary care, or emergency medicine.
ABIM MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Dr. Peek reports the following financial relationships:
Consultant: Pfizer Inc.
Dr. Bond reports no financial relationships to disclose.
Dr. Essien reports the following financial relationships:
Grants: Department of Veterans Affairs Health Services Research and Development Division
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).